October 4, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Stellar Biotechnologies narrows net losses

IN THIS ARTICLE

Stellar Biotechnologies reported earnings of $70,000 for its second quarter ended June 30 and narrowed its net losses 5 percent to $1.16 million. The company manufactures proteins derived from marine mollusks for use in immunotherapies out of Port Hueneme. It reported that expenses decreased for the quarter during which it raised $8.8 million, giving it…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.